Fingerprint
Dive into the research topics of 'Outcomes of Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Following an Elective Switch From Second-Generation Tyrosine Kinase Inhibitor to Imatinib'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically